Medico Remedies Statistics
Total Valuation
Medico Remedies has a market cap or net worth of INR 3.88 billion. The enterprise value is 3.99 billion.
| Market Cap | 3.88B |
| Enterprise Value | 3.99B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 82.98M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.80% |
| Shares Change (QoQ) | -0.94% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 20.08M |
Valuation Ratios
The trailing PE ratio is 33.47.
| PE Ratio | 33.47 |
| Forward PE | n/a |
| PS Ratio | 2.03 |
| PB Ratio | 5.81 |
| P/TBV Ratio | 5.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 34.40 |
| EV / Sales | 2.09 |
| EV / EBITDA | 24.12 |
| EV / EBIT | 29.60 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | n/a |
| Interest Coverage | 12.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.05% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.23% |
| Revenue Per Employee | 8.96M |
| Profits Per Employee | 544,573 |
| Employee Count | 213 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medico Remedies has paid 38.40 million in taxes.
| Income Tax | 38.40M |
| Effective Tax Rate | 24.87% |
Stock Price Statistics
The stock price has decreased by -30.37% in the last 52 weeks. The beta is 0.17, so Medico Remedies's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -30.37% |
| 50-Day Moving Average | 49.44 |
| 200-Day Moving Average | 47.28 |
| Relative Strength Index (RSI) | 43.80 |
| Average Volume (20 Days) | 505,034 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medico Remedies had revenue of INR 1.91 billion and earned 115.99 million in profits. Earnings per share was 1.40.
| Revenue | 1.91B |
| Gross Profit | 497.07M |
| Operating Income | 134.83M |
| Pretax Income | 154.39M |
| Net Income | 115.99M |
| EBITDA | 161.30M |
| EBIT | 134.83M |
| Earnings Per Share (EPS) | 1.40 |
Balance Sheet
The company has 17.64 million in cash and 125.27 million in debt, with a net cash position of -107.64 million.
| Cash & Cash Equivalents | 17.64M |
| Total Debt | 125.27M |
| Net Cash | -107.64M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 668.58M |
| Book Value Per Share | 8.07 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 26.04%, with operating and profit margins of 7.06% and 6.08%.
| Gross Margin | 26.04% |
| Operating Margin | 7.06% |
| Pretax Margin | 8.09% |
| Profit Margin | 6.08% |
| EBITDA Margin | 8.45% |
| EBIT Margin | 7.06% |
| FCF Margin | n/a |
Dividends & Yields
Medico Remedies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.80% |
| Shareholder Yield | 0.80% |
| Earnings Yield | 2.99% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 16, 2023. It was a forward split with a ratio of 5.
| Last Split Date | Mar 16, 2023 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |